Holding the Line: Pet Food Advocate Exposes Persistent FDA Silence, Regulatory Blind Spots, and Enforcement Gaps

By Regulatory Watch Desk
Published September 2026

Executive Summary and Main Facts

For millions of pet owners around the world, commercial pet food packaging serves as a trusted guide. Photos of fresh grilled chicken breasts, whole roasted turkeys, and pristine fish fillets adorn colorful bags, promising wholesome nutrition for beloved cats and dogs. However, behind these glossy marketing campaigns lies a contentious regulatory battleground where consumer advocates claim federal oversight has effectively ground to a halt.

Susan Thixton, a prominent pet food consumer advocate and founder of TruthaboutPetFood.com and the Association for Truth in Pet Food, has spent years pushing the U.S. Food and Drug Administration (FDA) to strictly enforce federal statutes governing the pet food industry. Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA is legally charged with ensuring that all animal foods—just like human foods—are safe to consume, manufactured under sanitary conditions, free of harmful substances, and truthfully labeled.

Yet, according to documented communications spanning several years, the agency’s Center for Veterinary Medicine (CVM) has repeatedly stonewalled inquiries, missed statutory deadlines, and avoided addressing fundamental questions regarding truth-in-labeling, slaughterhouse byproduct processing definitions, avian flu transparency, and major shifts in regulatory modernization.

The ongoing standoff highlights a troubling dynamic between federal regulators and the consumers they are mandated to protect. While the FDA maintains broad enforcement discretion, consumer advocates argue that this discretion has morphed into active negligence, leaving pet owners in the dark about what is actually inside their animals’ bowls.

Chronology of Regulatory Inquiries and Stonewalling

To understand the depth of the transparency crisis, one must examine the timeline of correspondence between consumer advocates and federal regulators. Over the past two years, multiple formal inquiries have been met with silence, bureaucratic deflection, or outright refusals to enforce the law.

1. The Meow Mix Labeling Inquiry (January 2026 – September 2026)

• January 28, 2026: TruthaboutPetFood.com formally petitioned the FDA to explain how a popular commercial product—Meow Mix Original Choice Cat Food—complies with federal truth-in-labeling mandates. The product packaging features vivid images of grilled chicken breast, roasted turkey, and fish fillets. However, a review of the ingredient panel reveals that these whole meats are absent, replaced instead by processed meals: chicken by-product meal, turkey by-product meal, salmon meal, and ocean fish meal.
• March 12, 2026: Having received no acknowledgment or reply, advocates sent a follow-up inquiry asking CVM to either provide an explanation or justify the agency’s silence.
• September 15, 2026: To date, the FDA has offered zero explanation as to how these pictorial representations meet the statutory requirement of being "truthfully labeled."

2. The Slaughterhouse "Tankage" Identification Inquiry (July 2026)

• July 6, 2026: Advocates pressed the FDA for clarity regarding how condemned materials processed in USDA slaughter facilities—commonly referred to in the industry as "tankage"—must be identified on pet food ingredient labels. Specifically, they asked whether tankage derived from a USDA chicken slaughter facility is legally required to be disclosed to consumers simply as "chicken" or "chicken meal."
• Current Status: The FDA failed to provide any substantive answer or clarification regarding these labeling designations.

3. Avian Flu Transparency and Risk Assessment (September 2025)

• September 15, 2025: Amid rising concerns over Highly Pathogenic Avian Influenza (HPAI), the FDA issued public warnings advising consumers against feeding raw pet foods due to potential contamination risks. Consumer advocates challenged the narrow scope of these warnings using official USDA statistics. Data showed that out of 145 diagnosed domestic cats since May 2022, only 4% of the cases had consumed a raw diet. Advocates formally asked the FDA for the missing epidemiological data: What diet style did the remaining 96% of cats consume? What percentage were strictly indoor cats versus outdoor cats?
• Current Status: The FDA ignored the questions entirely. Advocates argued that by focusing exclusively on raw diets while withholding critical data on the vast majority of cases (potentially kibble-fed or outdoor cats), the agency engaged in professional negligence that crippled pet owners’ ability to properly assess and mitigate risks.

4. AAFCO Pet Food Label Modernization Fallout (May 2025 – June 2026)

• May 29, 2025: Following the historic dissolution of the long-standing partnership and Memorandum of Understanding (MOU) between the FDA and the Association of American Feed Control Officials (AAFCO), advocates sought clarity. They asked whether sweeping updates developed under the AAFCO Pet Food Label Modernization initiative would still be recognized or implemented by the federal agency.
• June 2025 – June 2026: The FDA responded within a week, offering a generic form link directing stakeholders to an announcement regarding the expiring MOU. When advocates pointed out that the linked page contained zero information about Label Modernization, a follow-up inquiry was dispatched. The FDA’s subsequent response directed inquirers back to its previous, unhelpful statement, leaving the future of national label standardization shrouded in uncertainty.

5. The 1,333-Day Citizen Petition and Reconsideration Battle (2022 – 2026)

• July 2022: Fed up with deceptive industry practices, advocates filed a formal Citizen Petition with the FDA, citing numerous violations of federal law regarding misleading pet food ingredient names and demanding immediate regulatory enforcement.
• Days Pass: Although federal guidelines require the FDA to respond to Citizen Petitions within 180 days, the agency dragged its feet for an astonishing 1,333 days before finally issuing a formal denial. The FDA essentially stated it would not enforce the law as requested.
• April 13, 2026: Refusing to accept the dismissal, advocates filed a Petition for Reconsideration, supplying fresh, concrete evidence demonstrating how consumers continue to be misled by unpunished labeling practices. They requested a decision within a compressed 45-day window.
• September 15, 2026: Over 155 days have elapsed since the reconsideration request, and the FDA has yet to issue a single word of response.

Supporting Data and Industry Background

The ongoing conflict between consumer advocates and the federal regulator underscores deep structural flaws within the American pet food oversight apparatus. To contextualize these grievances, several key regulatory realities must be considered:

• The FD&C Act Mandate: Federal law explicitly dictates that pet food must be safe, wholesome, and truthfully labeled. Critics contend that allowing pictorial representations of whole, human-grade meats (such as grilled chicken breasts and whole fillets) on products containing exclusively rendered by-product meals is a direct violation of the truth-in-labeling mandate.
• Statistical Disparities in Disease Alerts: The controversy surrounding HPAI public health alerts highlights a dangerous communication gap. When federal agencies issue targeted warnings while withholding broader epidemiological contexts (such as the diets of the 96% of feline cases not linked to raw food), they undermine public trust. Pet owners cannot protect their animals if vital risk factors are obscured.
• The AAFCO Schism: For decades, AAFCO served as the primary standard-setting body for animal feed and pet food labeling in the United States, working in tandem with the FDA. With the expiration of their MOU, the regulatory framework governing pet food ingredients, nutritional adequacy statements, and label modernization has entered uncharted territory, leaving manufacturers and consumers uncertain about future compliance standards.
• Bureaucratic Delays: The 1,333-day delay in responding to the 2022 Citizen Petition highlights a systemic backlog or unwillingness within CVM to address substantive policy challenges raised by the public.

Official Responses and Institutional Silence

A recurring theme throughout this multi-year oversight effort is the stark contrast between public health messaging and direct accountability.

When queried on complex scientific or legal matters—such as slaughterhouse tankage definitions, avian flu vectors in various food formats, or label modernization integration—the FDA’s Center for Veterinary Medicine has repeatedly defaulted to procedural deflection. Standard automated replies, generic web links that fail to address the core questions, and prolonged periods of ghosting have become the norm for independent watchdogs seeking transparency.

Legal experts note that while federal agencies possess broad administrative discretion in prioritizing enforcement actions, chronic unresponsiveness to Citizen Petitions and Petitions for Reconsideration stretches administrative law to its limits. By missing statutory deadlines by years—such as the 1,333-day delay on the 2022 petition—the agency effectively shuts out public participation and judicial review.

Implications for Pet Owners and the Industry

The implications of the FDA’s regulatory vacuum extend far beyond bureaucratic friction; they directly impact public health, consumer pocketbooks, and animal welfare.

1. Erosion of Consumer Trust: When pet owners realize that pictures of fresh cuts of meat on a bag of kibble do not reflect the actual contents inside—and that federal regulators refuse to address or correct the discrepancy—trust in commercial brands and oversight bodies evaporates.
2. Compromised Pet Health: A lack of transparent communication regarding disease vectors—such as the unanswered questions surrounding avian flu in non-raw diets—prevents pet owners from making fully informed husbandry and feeding decisions.
3. An Uneven Playing Field: Ethical pet food manufacturers who invest in high-quality, whole-food ingredients face unfair competition from mass-market brands that leverage clever marketing illusions and rendered meals while enjoying tacit regulatory protection.
4. The Path Forward: Despite facing years of stone-walling, consumer advocacy groups like the Association for Truth in Pet Food have vowed to press forward. Through ongoing public education, independent product vetting (such as the annual trusted pet food and treat lists), and relentless petitioning, advocates continue to fill the void left by federal regulators.

As the pet food market continues to evolve amidst regulatory restructuring and emerging health challenges, the demand for government accountability has never been more urgent. Until the FDA bridges the gap between statutory mandates and actual enforcement, watchdogs like Susan Thixton will remain on the front lines, demanding the answers that pet owners deserve.